| |
| |
|
| Insider
Information: |
Struthers Richard Scott |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
257,485 |
|
|
Indirect Shares
|
901,805 |
|
|
| Direct
Value |
$13,103,412 |
|
|
|
Indirect Value
|
$45,892,856 |
|
|
| Total
Shares |
1,159,290 |
|
|
| Total
Value |
$58,996,268 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crinetics Pharmaceuticals, Inc. |
CRNX |
|
2024-04-18 |
257,485 |
2024-04-18 |
901,805 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2024-04-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
350 |
257,485 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2024-04-15 |
4 |
OE |
$1.91 |
$38,200 |
D/D |
20,000 |
257,835 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2024-04-04 |
4 |
AS |
$49.17 |
$2,013,561 |
D/D |
(40,951) |
237,835 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2024-04-04 |
4 |
OE |
$9.28 |
$380,025 |
D/D |
40,951 |
278,786 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2024-03-18 |
4 |
D |
$38.14 |
$483,882 |
D/D |
(12,687) |
237,835 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2024-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
250,522 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2024-02-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
60,000 |
570,805 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2024-02-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
60,000 |
110,000 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2023-11-09 |
4 |
OE |
$1.91 |
$95,500 |
D/D |
50,000 |
185,522 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2023-11-03 |
4 |
S |
$30.56 |
$6,083,946 |
D/D |
(199,082) |
135,522 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2023-11-03 |
4 |
OE |
$9.28 |
$1,847,481 |
D/D |
199,082 |
334,604 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2023-11-02 |
4 |
S |
$29.95 |
$27,494 |
D/D |
(918) |
135,522 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2023-11-02 |
4 |
OE |
$9.28 |
$8,519 |
D/D |
918 |
136,440 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2023-08-14 |
4 |
OE |
$1.91 |
$19,100 |
D/D |
10,000 |
135,522 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2023-07-13 |
4 |
S |
$20.35 |
$288,095 |
I/I |
(14,157) |
630,805 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2023-07-12 |
4 |
S |
$20.17 |
$231,128 |
I/I |
(11,459) |
644,962 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2023-07-11 |
4 |
S |
$20.14 |
$491,094 |
I/I |
(24,384) |
656,421 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2023-06-16 |
4 |
S |
$20.81 |
$1,040,500 |
I/I |
(50,000) |
680,805 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2023-03-16 |
4 |
D |
$17.12 |
$79,231 |
D/D |
(4,628) |
125,522 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
61,650 |
130,150 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2022-10-12 |
4 |
OE |
$1.91 |
$21,201 |
D/D |
11,100 |
68,500 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2022-04-05 |
4 |
AS |
$25.34 |
$541,225 |
I/I |
(21,357) |
869,448 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
53,400 |
57,400 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2021-09-07 |
4 |
AS |
$25.00 |
$750,000 |
I/I |
(30,000) |
90,000 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
President & CEO |
• • – |
2020-07-16 |
4 |
S |
$14.46 |
$253,108 |
I/I |
(17,500) |
890,805 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
